Haemonetics Corporation Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31)
Haemonetics Corporation (HAE) reported Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31) of $1.65 million for the 12-month period ending 2014-03-29, per its 10-K filed 2014-05-22.
Discontinued › Expense Statement › Income Tax
us-gaap:TaxBenefitFromStockOptionsExercised1 · last filed 2014-05-22
- Haemonetics Corporation tax benefit from stock options exercised (deprecated 2013-01-31) for the quarter ending 2014-03-29 was -$1.26M, a 534.95% decline year-over-year.
- Haemonetics Corporation tax benefit from stock options exercised (deprecated 2013-01-31) for the quarter ending 2013-06-29 was $840.00K, a 20.00% decline year-over-year.
- Haemonetics Corporation tax benefit from stock options exercised (deprecated 2013-01-31) for the quarter ending 2013-03-30 was $289.00K, a 47.26% decline year-over-year.
- Haemonetics Corporation tax benefit from stock options exercised (deprecated 2013-01-31) for the quarter ending 2012-12-29 was $1.42M.
- Haemonetics Corporation tax benefit from stock options exercised (deprecated 2013-01-31) for fiscal 2014 was $1.65M, a 60.68% decline from fiscal 2013.
- Haemonetics Corporation tax benefit from stock options exercised (deprecated 2013-01-31) for fiscal 2013 was $4.19M, a 114.20% increase from fiscal 2012.
- Haemonetics Corporation tax benefit from stock options exercised (deprecated 2013-01-31) for fiscal 2012 was $1.96M, a 60.37% decline from fiscal 2011.
- Haemonetics Corporation tax benefit from stock options exercised (deprecated 2013-01-31) for fiscal 2011 was $4.94M.
| Period end | Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31) 3 month | Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31) 6 month | Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31) 9 month | Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31) 12 month |
|---|---|---|---|---|
| 2014-03-29 | -$1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2014-05-22 | $1.65M 10-K · filed 2014-05-22 | ||
| 2013-12-28 | $2.91M 10-Q · filed 2014-01-30 | |||
| 2013-09-28 | $1.34M 10-Q · filed 2013-10-30 | |||
| 2013-06-29 | $840.00K 10-Q · filed 2013-08-02 | $1.13M derived: sum of 2 quarters · filed 2014-05-22 | $2.55M derived: sum of 3 quarters · filed 2014-05-22 | $3.98M derived: sum of 4 quarters · filed 2014-05-22 |
| 2013-03-30 | $289.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-05-22 | $1.71M derived: sum of 2 quarters · filed 2014-05-22 | $3.14M derived: sum of 3 quarters · filed 2014-05-22 | $4.19M 10-K · filed 2014-05-22 |
| 2012-12-29 | $1.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-01-30 | $2.85M derived: sum of 2 quarters · filed 2014-01-30 | $3.90M 10-Q · filed 2014-01-30 | $4.45M derived: sum of 4 quarters · filed 2014-05-22 |
| 2012-09-29 | $1.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-10-30 | $2.49M 10-Q · filed 2013-10-30 | $3.04M derived: sum of 3 quarters · filed 2014-05-22 | |
| 2012-06-30 | $1.05M 10-Q · filed 2013-08-02 | $1.60M derived: sum of 2 quarters · filed 2014-05-22 | ||
| 2012-03-31 | $548.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-05-22 | $1.96M 10-K · filed 2014-05-22 | ||
| 2011-12-31 | $1.41M 10-Q · filed 2013-02-01 | |||
| 2011-04-02 | $4.94M 10-K · filed 2013-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |